Herceptin

Feel better product launch visibility and first movers advantage to aid its financials; largely maintain buy call on the stock

To cut healthcare costs, US must partner India: Biocon's Shaw

Biocon Chief Kiran Mazumdar Shaw says India is not an outsourced services country anymore, it is an innovation and knowledge partner.

USFDA to review Biocon-Mylan's biosimilar drug for breast cancer

Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylan‘s biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.

Mylan, Biocon confirm efficacy of trastuzumab biosimilar

Global pharma major Mylan Inc, and Biocon have confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche's branded Herceptin used for treatment of cancer

Roche launches new breast cancer drugs in India

These targeted medicines represent a completely new way to treat HER2-positive metastatic breast cancer, with which the company aims to help women in India live as long and as well as possible, he added.

Roche gets break in case against India sales of cancer drug

The Delhi High Court (HC) has thrown a wrench into plans of Biocon and Mylan to market a breast cancer drug that goes by the scientific name Trastuzumab.

Mylan launches breast cancer drug in India

The company's subsidiary Mylan Pharmaceuticals Pvt Ltd has launched the world's first trastuzumab biosimilar, which will be marketed by Mylan under the brand name Hertraz Herceptin, a company statement said.

Biocon to start selling breast cancer drug in India in Feb

Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.

Chasing cheaper cancer drugs

In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.

Roche to sell cheaper cancer drugs in India

Roche Holding AG will launch two locally branded cancer drugs in India at "significantly lower" prices by the end of this year or early next year, a Roche spokesman said on Friday.